Garrison Point Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Sell
13,216
-1,099
-8% -$127K 0.73% 38
2025
Q4
$1.51M Sell
14,315
-2,124
-13% -$199K 0.67% 39
2025
Q3
$1.38M Sell
16,439
-1,254
-7% -$103K 0.58% 43
2025
Q2
$1.4M Buy
17,693
+1
+0% +$79 0.64% 41
2025
Q1
$1.59M Sell
17,692
-909
-5% -$84.9K 0.77% 38
2024
Q4
$1.85M Buy
18,601
+12,393
+200% +$1.28M 0.88% 29
2024
Q3
$705K Sell
6,208
-600
-9% -$71.3K 0.44% 69
2024
Q2
$843K Sell
6,808
-451
-6% -$58.1K 0.56% 55
2024
Q1
$958K Sell
7,259
-154
-2% -$19K 0.62% 52
2023
Q4
$808K Sell
7,413
-127
-2% -$13.2K 0.57% 60
2023
Q3
$776K Sell
7,540
-99
-1% -$10.7K 0.6% 55
2023
Q2
$881K Sell
7,639
-209
-3% -$23.7K 0.64% 50
2023
Q1
$835K Buy
7,848
+2,578
+49% +$278K 0.63% 53
2022
Q4
$585K Sell
5,270
-199
-4% -$20.3K 0.48% 76
2022
Q3
$471K Hold
5,469
0.42% 80
2022
Q2
$499K Buy
5,469
+1
+0% +$89 0.41% 78
2022
Q1
$449K Buy
5,468
+1
+0% +$79 0.31% 97
2021
Q4
$419K Buy
5,467
+86
+2% +$6.85K 0.28% 102
2021
Q3
$404K Buy
5,381
+1
+0% +$76 0.29% 105
2021
Q2
$418K Sell
5,380
-121
-2% -$9K 0.3% 102
2021
Q1
$405K Buy
5,501
+286
+5% +$21.1K 0.31% 98
2020
Q4
$407K Buy
5,215
+245
+5% +$18.7K 0.33% 92
2020
Q3
$393K Buy
4,970
+1
+0% +$78 0.36% 87
2020
Q2
$367K Sell
4,969
-41
-0.8% -$3.09K 0.36% 85
2020
Q1
$368K Sell
5,010
-209
-4% -$16.4K 0.45% 73
2019
Q4
$453K Sell
5,219
-212
-4% -$17.4K 0.42% 85
2019
Q3
$436K Sell
5,431
-50
-0.9% -$4.01K 0.43% 84
2019
Q2
$439K Sell
5,481
-108
-2% -$8.27K 0.44% 83
2019
Q1
$444K Sell
5,589
-155
-3% -$11.6K 0.46% 79
2018
Q4
$419K Buy
+5,744
New +$405K 0.52% 72

Other funds holding MRK

Garrison Point Advisors's MRK Position: Q1 2026 in Review

Garrison Point Advisors reduced its Merck (MRK) stake by 7.7% in Q1 2026, selling an estimated $127K and leaving 13,216 shares worth $1.59M. The position accounts for 0.73% of the portfolio, ranked #38.

Garrison Point Advisors first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.85M in Q4 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Garrison Point Advisors held 13,216 shares of Merck worth $1.59M as of Q1 2026.
  • Garrison Point Advisors sold 1,099 Merck shares in Q1 2026, an estimated $127K.
  • Merck made up 0.73% of Garrison Point Advisors's portfolio in Q1 2026, its #38 holding.
  • Garrison Point Advisors first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Garrison Point Advisors's Merck position peaked at $1.85M in Q4 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Garrison Point Advisors's 13F filing for Q1 2026, filed 13 May 2026.